- Home
- RF vs WST Comparison
RF vs WST Comparison
Compare RF & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RF
- WST
- Stock Information
- Founded
- RF 1970
- WST 1923
- Country
- RF United States
- WST United States
- Employees
- RF N/A
- WST N/A
- Industry
- RF Major Banks
- WST Medical/Dental Instruments
- Sector
- RF Finance
- WST Health Care
- Exchange
- RF Nasdaq
- WST Nasdaq
- Market Cap
- RF 23.8B
- WST 23.2B
- IPO Year
- RF N/A
- WST N/A
- Fundamental
- Price
- RF $23.98
- WST $333.19
- Analyst Decision
- RF Buy
- WST Strong Buy
- Analyst Count
- RF 18
- WST 5
- Target Price
- RF $27.33
- WST $437.75
- AVG Volume (30 Days)
- RF 7.8M
- WST 482.3K
- Earning Date
- RF 01-17-2025
- WST 02-13-2025
- Dividend Yield
- RF 4.17%
- WST 0.25%
- EPS Growth
- RF N/A
- WST N/A
- EPS
- RF 1.77
- WST 6.74
- Revenue
- RF $6,556,000,000.00
- WST $2,876,400,000.00
- Revenue This Year
- RF N/A
- WST N/A
- Revenue Next Year
- RF $5.36
- WST $6.08
- P/E Ratio
- RF $13.51
- WST $49.37
- Revenue Growth
- RF N/A
- WST N/A
- 52 Week Low
- RF $17.42
- WST $265.00
- 52 Week High
- RF $27.96
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- RF 37.16
- WST 58.32
- Support Level
- RF $23.01
- WST $325.33
- Resistance Level
- RF $24.02
- WST $335.53
- Average True Range (ATR)
- RF 0.58
- WST 7.63
- MACD
- RF -0.22
- WST 0.36
- Stochastic Oscillator
- RF 27.17
- WST 76.56
About RF Regions Financial Corporation
Regions Financial is a regional bank headquartered in Alabama, with branches primarily in the Southeastern and Midwestern United States. Regions primarily provides traditional commercial and retail banking and also offers mortgage services, asset management, wealth management, securities brokerage, and trust services.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.